Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
Amano H, Uchida H, Harada K, Narita A, Fumino S, Yamada Y, Kumano S, Abe M, Ishigaki T, Sakairi M, Shirota C, Tainaka T, Sumida W, Yokota K, Makita S, Karakawa S, Mitani Y, Matsumoto S, Tomioka Y, Muramatsu H, Nishio N, Osawa T, Taguri M, Koh K, Tajiri T, Kato M, Matsumoto K, Takahashi Y, Hinoki A.
Amano H, et al. Among authors: mitani y.
Cancer Sci. 2024 May;115(5):1634-1645. doi: 10.1111/cas.16116. Epub 2024 Feb 27.
Cancer Sci. 2024.
PMID: 38411285
Free PMC article.